• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丝氨酸蛋白酶抑制剂 3(SERPINB3)与预后不良的肝细胞癌中 TGF-β1 和细胞质 β-连环蛋白的表达相关。

SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis.

机构信息

Dept of Medicine, University of Padua, Padua, Italy.

Unit of Hepatobiliary Surgery and Liver Transplantation, University of Padua, Padua, Italy.

出版信息

Br J Cancer. 2014 May 27;110(11):2708-15. doi: 10.1038/bjc.2014.246. Epub 2014 May 8.

DOI:10.1038/bjc.2014.246
PMID:24809782
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4037839/
Abstract

BACKGROUND

Hepatocellular carcinoma (HCC) is one of the most important sanitary problems for its prevalence and poor prognosis. To date, no information is available on the prognostic value of the ov-serpin SERPINB3, detected in primary liver cancer but not in normal liver. The aim of the study was to analyse SERPINB3 expression in liver cancer in relation with molecular signatures of poor prognosis and with clinical outcome.

METHODS

Liver tumours of 97 patients were analysed in parallel for SERPINB3, TGF-β and β-catenin. In a subgroup of 67 patients with adequate clinical follow-up, the correlation of molecular findings with clinical outcome was also carried out.

RESULTS

High SERPINB3 levels were detectable in 22% of the patients. A significant correlation of this serpin with TGF-β at transcription and protein level was observed, whereas for β-catenin a strong correlation was found only at post-transcription level. These findings were in agreement with transcriptome data meta-analysis, showing accumulation of SERPINB3 in the poor-prognosis subclass (S1). High levels of this serpin were significantly associated with early tumour recurrence and high SERPINB3 was the only variable significantly associated with time to recurrence at multivariate analysis.

CONCLUSIONS

SERPINB3 is overexpressed in the subset of the most aggressive HCCs.

摘要

背景

肝细胞癌 (HCC) 是一个重要的卫生问题,因为其发病率高且预后不良。迄今为止,尚无关于在原发性肝癌中检测到但在正常肝脏中未检测到的 ov-serpin SERPINB3 的预后价值的信息。本研究旨在分析 SERPINB3 在肝癌中的表达与不良预后的分子特征以及临床结果的关系。

方法

对 97 例患者的肝脏肿瘤进行平行分析,以检测 SERPINB3、TGF-β 和 β-catenin。在 67 例具有充足临床随访的患者亚组中,还进行了分子发现与临床结果的相关性分析。

结果

在 22%的患者中可检测到高水平的 SERPINB3。观察到该丝氨酸蛋白酶与转录和蛋白水平的 TGF-β 显著相关,而对于 β-catenin,仅在转录后水平发现强烈相关性。这些发现与转录组数据荟萃分析一致,表明 SERPINB3 在预后不良亚组 (S1) 中积累。高水平的这种丝氨酸蛋白酶与肿瘤早期复发显著相关,并且在多变量分析中,高 SERPINB3 是唯一与复发时间显著相关的变量。

结论

SERPINB3 在最具侵袭性的 HCC 亚组中过度表达。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef42/4037839/16986832e688/bjc2014246f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef42/4037839/0ebd11d928e7/bjc2014246f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef42/4037839/14a17a0bde56/bjc2014246f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef42/4037839/4ba7f7f1f0f4/bjc2014246f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef42/4037839/a285b2738737/bjc2014246f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef42/4037839/d5a9dbf947cf/bjc2014246f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef42/4037839/16986832e688/bjc2014246f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef42/4037839/0ebd11d928e7/bjc2014246f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef42/4037839/14a17a0bde56/bjc2014246f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef42/4037839/4ba7f7f1f0f4/bjc2014246f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef42/4037839/a285b2738737/bjc2014246f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef42/4037839/d5a9dbf947cf/bjc2014246f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef42/4037839/16986832e688/bjc2014246f6.jpg

相似文献

1
SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis.丝氨酸蛋白酶抑制剂 3(SERPINB3)与预后不良的肝细胞癌中 TGF-β1 和细胞质 β-连环蛋白的表达相关。
Br J Cancer. 2014 May 27;110(11):2708-15. doi: 10.1038/bjc.2014.246. Epub 2014 May 8.
2
SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancer.丝氨酸蛋白酶抑制剂B3上调结直肠癌中的环氧化酶-2/β-连环蛋白正反馈环。
Oncotarget. 2017 Feb 28;8(9):15732-15743. doi: 10.18632/oncotarget.14997.
3
SERPINB3 modulates TGF-beta expression in chronic liver disease.丝氨酸蛋白酶抑制剂 B3 调节慢性肝病中的 TGF-β表达。
Lab Invest. 2010 Jul;90(7):1016-23. doi: 10.1038/labinvest.2010.55. Epub 2010 Mar 8.
4
SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma.丝氨酸蛋白酶抑制剂 B3 诱导肝癌中二肽基肽酶 IV/CD26 的表达及其代谢作用。
Life Sci. 2018 May 1;200:134-141. doi: 10.1016/j.lfs.2018.03.014. Epub 2018 Mar 7.
5
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells.缺氧通过缺氧诱导因子-2α上调人肝癌细胞中的丝氨酸蛋白酶抑制剂B3。
Oncotarget. 2015 Feb 10;6(4):2206-21. doi: 10.18632/oncotarget.2943.
6
Role of p53 and β-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma.p53 和 β-catenin 突变与 CK19 表达在肝癌早期复发和预后中的作用。
J Gastrointest Surg. 2011 Feb;15(2):321-9. doi: 10.1007/s11605-010-1373-x.
7
The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.转化生长因子-β1(TGF-β1)与ELF联合检测在肝细胞癌中的预后价值
BMC Cancer. 2015 Mar 11;15:116. doi: 10.1186/s12885-015-1127-y.
8
Role of SERPINB3 in hepatocellular carcinoma.丝氨酸蛋白酶抑制剂B3(SERPINB3)在肝细胞癌中的作用。
Ann Hepatol. 2014 Nov-Dec;13(6):722-7.
9
High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resection.肝癌中 micro RNA-135A 的高表达与术后 12 个月内的复发相关。
BMC Cancer. 2017 Jan 18;17(1):60. doi: 10.1186/s12885-017-3053-7.
10
Low expression of c-Myc protein predicts poor outcomes in patients with hepatocellular carcinoma after resection.c-Myc 蛋白低表达预示着肝癌患者手术后预后不良。
BMC Cancer. 2018 Apr 24;18(1):460. doi: 10.1186/s12885-018-4379-5.

引用本文的文献

1
The impact of serpinB3-PD polymorphism on the prognosis of patients with hepatocellular carcinoma.丝氨酸蛋白酶抑制剂B3基因多态性对肝细胞癌患者预后的影响。
Transl Oncol. 2025 Jul;57:102413. doi: 10.1016/j.tranon.2025.102413. Epub 2025 May 13.
2
SerpinB3: A Multifaceted Player in Health and Disease-Review and Future Perspectives.丝氨酸蛋白酶抑制剂B3:健康与疾病中的多面角色——综述与未来展望
Cancers (Basel). 2024 Jul 18;16(14):2579. doi: 10.3390/cancers16142579.
3
SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma.

本文引用的文献

1
Hepatic progenitor cells express SerpinB3.肝祖细胞表达丝氨酸蛋白酶抑制剂B3。
BMC Cell Biol. 2014 Feb 11;15:5. doi: 10.1186/1471-2121-15-5.
2
MicroRNAs miR-146-5p and let-7f as prognostic tools for aggressive papillary thyroid carcinoma: a case report.微小RNA miR-146-5p和let-7f作为侵袭性乳头状甲状腺癌的预后评估指标:一例报告
Arq Bras Endocrinol Metabol. 2012 Nov;56(8):552-7. doi: 10.1590/s0004-27302012000800015.
3
Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib.
丝氨酸蛋白酶抑制剂B3/4表达与胆管癌患者的不良预后相关。
Cancers (Basel). 2024 Jan 3;16(1):225. doi: 10.3390/cancers16010225.
4
Novel Molecular Targets for Immune Surveillance of Hepatocellular Carcinoma.肝细胞癌免疫监视的新型分子靶点
Cancers (Basel). 2023 Jul 15;15(14):3629. doi: 10.3390/cancers15143629.
5
SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness.丝氨酸蛋白酶抑制剂B3上调低密度脂蛋白受体相关蛋白(LRP)家族成员,导致Wnt信号激活以及细胞存活率和侵袭性增加。
Biology (Basel). 2023 May 26;12(6):771. doi: 10.3390/biology12060771.
6
Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition.针对 SerpinB3 的表位特异性抗体用于 SerpinB3 的识别和生物学活性抑制。
Biomolecules. 2023 Apr 25;13(5):739. doi: 10.3390/biom13050739.
7
Inflammatory processes involved in NASH-related hepatocellular carcinoma.与 NASH 相关的肝细胞癌中的炎症过程。
Biosci Rep. 2023 Jan 31;43(1). doi: 10.1042/BSR20221271.
8
SerpinB3 administration protects liver against ischemia-reperfusion injury.SerpinB3 给药可保护肝脏免受缺血再灌注损伤。
Eur J Histochem. 2022 Oct 28;66(4):3561. doi: 10.4081/ejh.2022.3561.
9
Effects of Sensitized Sorafenib with a Paeoniflorin and Geniposide Mixture on Liver Cancer via the NF-B-HIF-2-SerpinB3 Pathway.芍药苷和栀子苷混合物致敏的索拉非尼通过NF-κB-HIF-2-SerpinB3途径对肝癌的影响
Evid Based Complement Alternat Med. 2022 Oct 15;2022:1911311. doi: 10.1155/2022/1911311. eCollection 2022.
10
Biological Pathway-Derived TMB Robustly Predicts the Outcome of Immune Checkpoint Blockade Therapy.生物途径衍生的 TMB 可稳健预测免疫检查点阻断治疗的结果。
Cells. 2022 Sep 8;11(18):2802. doi: 10.3390/cells11182802.
Wnt 通路在两种肝癌分子亚型中的激活作用及索拉非尼的实验调节作用。
Clin Cancer Res. 2012 Sep 15;18(18):4997-5007. doi: 10.1158/1078-0432.CCR-11-2322. Epub 2012 Jul 18.
4
IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease.慢性肝病患者血清中的 IgM 结合型 SerpinB3 和 SerpinB4。
PLoS One. 2012;7(7):e40658. doi: 10.1371/journal.pone.0040658. Epub 2012 Jul 13.
5
Fibrosis-dependent mechanisms of hepatocarcinogenesis.纤维化依赖的肝癌发生机制。
Hepatology. 2012 Aug;56(2):769-75. doi: 10.1002/hep.25670. Epub 2012 Jun 29.
6
Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma.miRNA 特征在肝细胞癌患者中的诊断和治疗潜力。
J Hepatol. 2012 Jun;56(6):1371-83. doi: 10.1016/j.jhep.2011.11.026. Epub 2012 Feb 5.
7
Aberrant expression of chromogranin A, miR-146a, and miR-146b-5p in prostate structures with focally disrupted basal cell layers: an early sign of invasion and hormone-refractory cancer?在局灶性基底细胞层中断的前列腺结构中染色质粒蛋白 A、miR-146a 和 miR-146b-5p 的异常表达:浸润和激素难治性癌症的早期标志?
Cancer Genomics Proteomics. 2011 Sep-Oct;8(5):235-44.
8
Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.转化生长因子-β信号促进 p53 缺失诱导的肝癌发生。
Hepatology. 2012 Jan;55(1):121-31. doi: 10.1002/hep.24653. Epub 2011 Dec 6.
9
Over-expression of SERPINB3 in hepatoblastoma: a possible insight into the genesis of this tumour?肝母细胞瘤中 SERPINB3 的过度表达:这种肿瘤发生的可能机制?
Eur J Cancer. 2012 May;48(8):1219-26. doi: 10.1016/j.ejca.2011.06.004. Epub 2011 Jul 5.
10
Management of hepatocellular carcinoma: an update.肝细胞癌的管理:最新进展
Hepatology. 2011 Mar;53(3):1020-2. doi: 10.1002/hep.24199.